Developability Classification System for Drugs
WEBINAR
The developability classification system (DCS) was proposed as a modification of the BCS to assist in the formulation of poorly soluble compounds. The DCS introduced two new compound categories: dissolution limited (DCS IIa) and solubility limited (DCS IIb). For DCS IIa molecules, particle size reduction and wetting agents can be considered. For DCS IIb compounds, solid-state modification can be utilized. Tune in to our webinar on the developability classification system to learn more about this emerging field of research, which allows more targeted and optimized formulation development of poorly soluble compounds.
Webinar Information
Pharma and biopharma manufacturing
- Solid Formulation Strategies
Duration:1h
Language:English
Session 1:presented November 2, 2021